CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 235 enrolled
Drug / intervention
Doppler endoscopic ultrasound probe for blood flow detection +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00732212
NCT00732212N/ACompleted

Doppler Ultrasound Probe for Blood Flow Detection in Severe UGI Bleed

VA Office of Research and Development·interventional·Posted Aug 11, 2008·Updated Dec 4, 2023

In Brief

A clinical study evaluating Doppler endoscopic ultrasound probe for blood flow detection and Standard endoscopic hemostasis for UGI Bleeding and 4 related conditions. Completed, enrolled 235 participants across 2 sites.

Detailed Summary

The main purposes of this study are to compare clinical outcomes of two groups of patients with similar medical conditions (one with non-variceal upper gastrointestinal (UGI) lesions such as ulcers and another group with varices or portal hypertensive lesions) who are treated either with current standard visually guided endoscopic treatment according to stigmata of hemorrhage or with endoscopic Doppler endoscopic ultrasound probe (DEP) monitoring of blood flow in the lesion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 11, 2008
Enrollment StartFeb 18, 2009
Primary CompletionJan 7, 2016
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 17.9 years ago

Interventions

Doppler endoscopic ultrasound probe for blood flow detectiondevice

Used for blood flow detection

Standard endoscopic hemostasisother

Per current treatment guidelines for non-variceal UGI lesions - based upon stigmata of hemorrhage \& visual cues for risk stratification and completion of endoscopic treatment.